Elevation of serum KL-6 levels during treatment with tumor necrosis factor-α inhibitor in patients with psoriasis.
Department of Dermatology, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Tomotaka
T
Mabuchi
Hanako
H
Yamaoka
Mayu
M
Kawai
Tami
T
Ota
Akira
A
Ozawa
D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018396:Mucin-1 / Q000097:blood*; D011565:Psoriasis / Q000188:drug therapy*; D012189:Retrospective Studies; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; C060192:MUC1 protein, human; D018396:Mucin-1; D014409:Tumor Necrosis Factor-alpha